We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$260M
AUM Growth
-$5.39M
Cap. Flow
-$8.14M
Cap. Flow %
-3.13%
Top 10 Hldgs %
99.91%
Holding
56
New
4
Increased
2
Reduced
3
Closed
37

Top Buys

Rank Stock Value
1
BBRE icon
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
+$10.2M
2
BEAM icon
Beam Therapeutics
BEAM
+$2.36M
3
DE icon
Deere & Co
DE
+$24.4K
4
HESM icon
Hess Midstream
HESM
+$9.9K
5
BR icon
Broadridge
BR
+$6.44K

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$5.88M
2
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$5.52M
3
WTTR icon
Select Water Solutions
WTTR
+$4.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$335K
5
HD icon
Home Depot
HD
+$316K

Sector Composition

Rank Sector Weight
1 Technology 3.25%
2 Healthcare 2.74%
3 Industrials 0.01%
4 Energy 0%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBRE icon
1
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.25B
$220M 84.53%
2,654,694
+118,905
+5% +$10.2M
EOCW.U
2
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$20.5M 7.86%
2,000,000
– –
TXN icon
3
Texas Instruments
TXN
$253B
$5.95M 2.29%
32,000
– –
IMTX icon
4
Immatics
IMTX
$1.33B
$4.81M 1.85%
697,431
– –
VT icon
5
Vanguard Total World Stock ETF
VT
$81.4B
$2.72M 1.05%
29,585
– –
HCP
6
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2.51M 0.96%
85,603
-184,989
-68% -$5.52M
BEAM icon
7
Beam Therapeutics
BEAM
$2.76B
$1.83M 0.7%
+59,839
New +$2.36M
BOND icon
8
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$1.44M 0.55%
15,502
– –
APEN
9
DELISTED
Apollo Endosurgery, Inc.
APEN
$155K 0.06%
15,601
-15,601
-50% -$155K
CDAK
10
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$148K 0.06%
847,108
– –
LXRX icon
11
Lexicon Pharmaceuticals
LXRX
$1.05B
$87K 0.03%
35,714
– –
SYRE icon
12
Spyre Therapeutics
SYRE
$9.18B
$71K 0.03%
9,827
– –
DE icon
13
Deere & Co
DE
$167B
$26K 0.01%
63
+59
+1,475% +$24.4K
TFFP
14
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$15K 0.01%
883
– –
HESM icon
15
Hess Midstream
HESM
$5.14B
$10K ﹤0.01%
+340
New +$9.9K
PLXP
16
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$8K ﹤0.01%
62,673
-62,673
-50% -$12.7K
BR icon
17
Broadridge
BR
$19.3B
$7K ﹤0.01%
+45
New +$6.44K
POR icon
18
Portland General Electric
POR
$5.74B
$6K ﹤0.01%
118
– –
PG icon
19
Procter & Gamble
PG
$335B
$3K ﹤0.01%
+18
New +$2.57K
AAPL icon
20
Apple
AAPL
$4.41T
– –
-476
Closed -$62K
ABBV icon
21
AbbVie
ABBV
$440B
– –
-1,500
Closed -$242K
ADP icon
22
Automatic Data Processing
ADP
$107B
– –
-1,000
Closed -$239K
CAT icon
23
Caterpillar
CAT
$393B
– –
-1,000
Closed -$240K
COST icon
24
Costco
COST
$421B
– –
-50
Closed -$23K
CSCO icon
25
Cisco
CSCO
$488B
– –
-125
Closed -$6K
1
2 3

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q1 2023 Portfolio in Review

As of Q1 2023, University of Texas/Texas AM Investment Management Co (UTIMCO) held 56 positions worth $260M, down 2% from $266M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $8.14M in Q1 2023, closing 37 positions and reducing 3 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $5.88M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Beam Therapeutics worth $1.83M.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q1 2023 buy was Beam Therapeutics: 59,839 shares worth $1.83M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to JPMorgan BetaBuilders MSCI US REIT ETF in Q1 2023, an estimated $10.2M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q1 2023 reduction was HashiCorp, Inc. Class A Common Stock, cutting an estimated $5.52M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2023, selling an estimated $5.88M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 100% of its $260M portfolio in Q1 2023.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 4 new positions and closed 37 in Q1 2023.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 2% quarter-over-quarter to $260M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2023, filed 22 May 2023.